Canada Prime Minister Justin Trudeau places emphasis on biological approaches being the future of medicine as he broadcasts government funding for establishment of the Center for Advanced Therapeutic Cell Technologies. See video of his announcement and key points below!
Key Points Include:
- Trudeau announces a $20 million grant to the Center for Commercialization of Regenerative Medicine (CCRM), to create a Toronto-based facility dedicated to development of new stem cell therapies
- CCRM, partnered with GE Healthcare, will establish the Center for Advanced Therapeutic Cell Technologies, which will be the first facility of its kind to use a collaborative approach between research institutions and industry to solve problems in cell therapy manufacturing
- With the biotechnology industry projected to expand exponentially within the next decade, the new center ought to position Canada as a major contributor to the global stem cell market
Want to be better informed than your competition? Get future stem cell industry updates.
About Us
BioInformant is the only research firm that has served the stem cell sector since it emerged. Our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and applies these techniques to the field of market research. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, and Becton Dickinson, BioInformant is your global leader in stem cell industry data.
Click here to view our global strategic reports for the stem cell and cord blood industry.